Skip to main content
. 2012 Jun 12;6(6):e1671. doi: 10.1371/journal.pntd.0001671

Figure 5. In vitro infection assay optimization for four Leishmania species.

Figure 5

A) Images illustrating the infection of THP1 human macrophages by Leishmania species that causes diseases with different clinical manifestations: L. amazonensis (diffuse cutaneous), L. braziliensis (mucocutaneous), L. donovani (visceral) and L. major (cutaneous). B) Dose response curves for the reference drug amphotericin B against all four species.